Vanguard Group
COCH icon

Vanguard Group’s Envoy Medical COCH Stock Holding History

Vanguard Group’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$230K Buy
347,300
+8,190
+2% +$6.49K ﹤0.01% 4091
2025
Q3 		$263K Sell
339,110
-55,851
-14% -$75.8K ﹤0.01% 4080
2025
Q2 		$561K Hold
394,961
– – ﹤0.01% 3895
2025
Q1 		$513K Hold
394,961
– – ﹤0.01% 3881
2024
Q4 		$581K Buy
394,961
+209,000
+112% +$475K ﹤0.01% 3902
2024
Q3 		$604K Buy
185,961
+70,033
+60% +$190K ﹤0.01% 3920
2024
Q2 		$274K Buy
115,928
+17,538
+18% +$65.2K ﹤0.01% 4115
2024
Q1 		$386K Buy
+98,390
New +$288K ﹤0.01% 4072

Other funds holding COCH

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group's COCH Position: Q4 2025 in Review

Vanguard Group increased its Envoy Medical (COCH) stake by 2.4% in Q4 2025, buying an estimated $6.49K and bringing the position to 347,300 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #4091.

Vanguard Group first reported a position in COCH in Q1 2024 and has held it in 8 quarters since. The position peaked at $604K in Q3 2024. 27 funds tracked by Wall St. Rank hold COCH as of Q4 2025.

  • Vanguard Group held 347,300 shares of Envoy Medical worth $230K as of Q4 2025.
  • Vanguard Group bought 8,190 Envoy Medical shares in Q4 2025, an estimated $6.49K.
  • Envoy Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4091 holding.
  • Vanguard Group first reported a position in Envoy Medical in Q1 2024 and has held it in 8 quarters since.
  • Vanguard Group's Envoy Medical position peaked at $604K in Q3 2024.
  • 27 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.